Literature DB >> 10785572

Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events.

G Schulgen1, A Kropec, I Kappstein, F Daschner, M Schumacher.   

Abstract

Infections acquired in hospital are likely to affect the duration of hospitalization. Suitable statistical methods for estimating the extra days spent in hospital due to nosocomial infections should allow modeling of the heterogeneity of the patient population and the timing of events, as failure to account for important covariates and failure to model adequately the timing of events may lead to biased results. Three approaches have been used in the past to estimate the extra stay: a comparison of duration of stay of infected and uninfected patients, matching of infected and uninfected patients with respect to potentially important determinants of the length of hospital stay, and matching for time-to-infection in addition to the other factors. While these approaches can allow for the heterogeneity of the patient population, none takes sufficient account of the real timing of events and may overestimate the effect of nosocomial infections. We explored the statistical methods available for analyzing time-to-event data and derived alternative methods to estimate the extra stay that appropriately account for heterogeneity and timing. Data from two prospective cohort studies on postoperative wound infection and on nosocomial pneumonia showed that the two-group comparison yields the highest estimates of extra stay (21 and 14 extra days), while matching for confounders and time reduced the estimates to 11 and 8 extra days; our methods yield even lower results (10-12 and 3-4 extra days).

Entities:  

Mesh:

Year:  2000        PMID: 10785572     DOI: 10.1016/s0895-4356(99)00182-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  12 in total

1.  Surgical site infection - a European perspective of incidence and economic burden.

Authors:  David J Leaper; Harry van Goor; Jacqueline Reilly; Nicola Petrosillo; Heinrich K Geiss; Antonio J Torres; Anne Berger
Journal:  Int Wound J       Date:  2004-12       Impact factor: 3.315

2.  Modeling the effect of time-dependent exposure on intensive care unit mortality.

Authors:  Martin Wolkewitz; Jan Beyersmann; Petra Gastmeier; Martin Schumacher
Journal:  Intensive Care Med       Date:  2009-01-31       Impact factor: 17.440

3.  The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.

Authors:  Tara Lagu; Mihaela S Stefan; Sarah Haessler; Thomas L Higgins; Michael B Rothberg; Brian H Nathanson; Nicholas S Hannon; Jay S Steingrub; Peter K Lindenauer
Journal:  J Hosp Med       Date:  2014-04-09       Impact factor: 2.960

4.  Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study.

Authors:  Alexander M Aiken; Neema Mturi; Patricia Njuguna; Shebe Mohammed; James A Berkley; Isaiah Mwangi; Salim Mwarumba; Barnes S Kitsao; Brett S Lowe; Susan C Morpeth; Andrew J Hall; Iqbal Khandawalla; J Anthony G Scott
Journal:  Lancet       Date:  2011-11-29       Impact factor: 79.321

5.  A multi-center nested case-control study on hospitalization costs and length of stay due to healthcare-associated infection.

Authors:  Yu Lü; Min Hong Cai; Jian Cheng; Kun Zou; Qian Xiang; Jia Yu Wu; Dao Qiong Wei; Zhong Hua Zhou; Hui Wang; Chen Wang; Jing Chen
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-09       Impact factor: 4.887

6.  Burden, spectrum, and impact of healthcare-associated infection at a South African children's hospital.

Authors:  A Dramowski; A Whitelaw; M F Cotton
Journal:  J Hosp Infect       Date:  2016-09-01       Impact factor: 3.926

7.  Clinical Analysis and Management of Long-Stay Patients.

Authors:  Chienhsiu Huang
Journal:  Int J Gen Med       Date:  2021-06-04

8.  Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models.

Authors:  Martin Wolkewitz; Ralf Peter Vonberg; Hajo Grundmann; Jan Beyersmann; Petra Gastmeier; Sina Bärwolff; Christine Geffers; Michael Behnke; Henning Rüden; Martin Schumacher
Journal:  Crit Care       Date:  2008-04-02       Impact factor: 9.097

9.  Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission.

Authors:  Michal Chowers; Yehuda Carmeli; Pnina Shitrit; Asher Elhayany; Keren Geffen
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.

Authors:  Tobias Siegfried Kramer; Cornelius Remschmidt; Sven Werner; Michael Behnke; Frank Schwab; Guido Werner; Petra Gastmeier; Rasmus Leistner
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-14       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.